The feasibility study of 64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer

被引：0
|
作者：
Yonemori, Kan [1 ]
Tamura, Kenji [1 ]
Kurihara, Hiroaki [3 ]
Kono, Yuzuru [3 ]
Arai, Yasuaki [3 ]
Wada, Yasuhiro [2 ]
Takahashi, Kazuhiro [3 ]
Hasegawa, Koki [3 ]
Watanabe, Yasuyoshi [3 ]
Fujiwara, Yasuhiro [1 ]
机构：
[1] Natl Canc Ctr Hosp Tokyo, Breast & Med Oncol, Tokyo, Japan
[2] RIKEN, Ctr Mol Imaging Sci, Kobe, Hyogo, Japan
[3] Natl Canc Ctr Hosp Tokyo, Nucl Med, Tokyo, Japan
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1266
引用
收藏
页数：2
相关论文
共 50 条
  • [1] 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
    Tamura, Kenji
    Kurihara, Hiroaki
    Yonemori, Kan
    Tsuda, Hitoshi
    Suzuki, Junko
    Kono, Yuzuru
    Honda, Natsuki
    Kodaira, Makoto
    Yamamoto, Harukaze
    Yunokawa, Mayu
    Shimizu, Chikako
    Hasegawa, Koki
    Kanayama, Yousuke
    Nozaki, Satoshi
    Kinoshita, Takayuki
    Wada, Yasuhiro
    Tazawa, Shusaku
    Takahashi, Kazuhiro
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) : 1869 - 1875
  • [2] 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
    Kurihara, Hiroaki
    Hamada, Akinobu
    Yoshida, Masayuki
    Shimma, Schuichi
    Hashimoto, Jun
    Yonemori, Kan
    Tani, Hitomi
    Miyakita, Yasuji
    Kanayama, Yousuke
    Wada, Yasuhiro
    Kodaira, Makoto
    Yunokawa, Mayu
    Yamamoto, Harukaze
    Shimizu, Chikako
    Takahashi, Kazuhiro
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    Tamura, Kenji
    EJNMMI RESEARCH, 2015, 5
  • [3] 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
    Hiroaki Kurihara
    Akinobu Hamada
    Masayuki Yoshida
    Schuichi Shimma
    Jun Hashimoto
    Kan Yonemori
    Hitomi Tani
    Yasuji Miyakita
    Yousuke Kanayama
    Yasuhiro Wada
    Makoto Kodaira
    Mayu Yunokawa
    Harukaze Yamamoto
    Chikako Shimizu
    Kazuhiro Takahashi
    Yasuyoshi Watanabe
    Yasuhiro Fujiwara
    Kenji Tamura
    EJNMMI Research, 5
  • [4] 64Cu-DOTA-trastuzumab-PET imaging in patients with HER2-positive breast cancer
    Tamura, Kenji
    Kurihara, Hiroaki
    Yonemori, Kan
    Takahashi, Kazuhiro
    Wada, Yasuhiro
    Hasegawa, Koki
    Koizumi, Fumiaki
    Tsuda, Hitoshi
    Kodaira, Makoto
    Yunokawa, Mayu
    Shimizu, Chikako
    Ando, Masashi
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] 64CU-DOTA-TRASTUZUMAB-PET IMAGING IN PATIENTS WITH HER2-POSITIVE BREAST CANCER
    Tamura, K.
    Yonemori, K.
    Kurihara, H.
    Kodaira, M.
    Yunokawa, M.
    Shimizu, C.
    Ando, M.
    Fujiwara, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 40 - 40
  • [6] 64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer
    Sasada, S.
    Kurihara, H.
    Kinoshita, T.
    Yoshida, M.
    Honda, N.
    Shimoi, T.
    Shimomura, A.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Hamada, A.
    Kanayama, Y.
    Watanabe, Y.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 2028 - 2029
  • [7] 64Cu-DOTA-trastuzumab imaging in a HER2-positive intracranial patient-derived xenograft (PDX) model of breast cancer metastasis
    Kristensen, Lotte
    Nielsen, Carsten
    Nedergaard, Mette
    Knudsen, Camilla
    Christensen, Camilla
    Wick, Michael
    Papadopoulos, Kyri
    Tolcher, Anthony
    Kjaer, Andreas
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [8] 64Cu-DOTA-trastuzumab PET/CT to predict response to ado-trastuzumab emtansine (TDM1) in HER2-positive metastatic breast cancer.
    Mortimer, Joanne E.
    Bading, James R.
    Frankel, Paul Henry
    Gidwaney, Rita
    Park, John
    Tumyan, Lusine
    Parayno, Maria
    Poku, Kofi
    Colcher, David
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] 64Cu DOTA-trastuzumab (64Cu-Herceptin)/PET effectively visualizes metastatic breast cancer in HER2-positive patients
    Bading, J.
    Conti, Peter
    Tong, Shan
    Reyes, J.
    Carroll, Mary
    Poku, Erasmus
    Miles, Joshua
    Colcher, David
    Raubitschek, Andrew
    Mortimer, Joanne
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [10] Visualization of HER2-specific breast cancer intratumoral heterogeneity using 64Cu-DOTA-trastuzumab PET
    Sasada, Shinsuke
    Kurihara, Hiroaki
    Kinoshita, Takayuki
    Yoshida, Masayuki
    Honda, Natsuki
    Shimoi, Tatsunori
    Shimomura, Akihiko
    Yonemori, Kan
    Shimizu, Chikako
    Hamada, Akinobu
    Kanayama, Yousuke
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    Tamura, Kenji
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) : 2146 - 2147
12345